CERS: Cerus Corp Company Profile & Statistics

About

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.

Info & Links

CEO

William M. Greenman

Headquarters

1220 CONCORD AVENUE, SUITE 600
CONCORD, CA 94520, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

115

Employees

281

Cerus Corp Statistics

Valuation Measures

Market Capitalization²

258.26M

Enterprise Value

323.75M

Enterprise Value/EBITDA(ttm)

-30.64

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.79

Price to Book(mrq)

5.95

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

60.68%

Operating Margin(ttm)

-11.60%

Profit Margin(ttm)

-9.37%

Return on Equity(ttm)

-40.55%

Return on Invested Capital(ttm)

-15.95%

Return on Assets(ttm)

-11.12%

Income Statement

Revenue(ttm)

206.78M

Revenue Per Share(ttm)

1.08

Gross Profit(ttm)

125.31M

EBITDA(ttm)³

-10.57M

Net Income Available to Common(ttm)

-18.95M

Diluted EPS(ttm)

-0.11

Share Statistics

Beta (5Y Monthly)

1.29

52-Week Change

-23.85%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

191.16M

Dividend Yield

0.00%

Float⁴

179.40M

% Held by Insiders

3.40%

% Held by Institutions

78.37%

Balance Sheet

Total Cash(mrq)

80.92M

Total Cash Per Share(mrq)

0.42

Total Debt(mrq)

84.97M

Total Debt/Equity(mrq)

151.08%

Current Ratio(mrq)

2.32%

Quick Ratio(mrq)

1.92%

Book Value Per Share(mrq)

0.29

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.00

Free Cash Flow(ytd)

-956.00K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CERS

Cerus Corp

Cerus Corp Profile